Cesca Therapeutics’ Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR-T Manufacturing Process … – GlobeNewswire (press release)
|
Cesca Therapeutics' Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR–T Manufacturing Process …
GlobeNewswire (press release) RANCHO CORDOVA, Calif., May 23, 2018 (GLOBE NEWSWIRE) — Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced … |
